NSEUpdates7 Sept 2026 · 7 Sept 2026, 05:25 pm

Updates

Neuland Laboratories Limited · NEULANDLAB

✦ AI SummaryExpansion

Neuland Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI Listing Regulations' for the purchase of approximately 134 acres of land for future expansion.

Analysis Scores

Earnings Impact5/10
Growth Catalyst8/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk3/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Neuland Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI Listing Regulations'.

Attachments (1)

📄

NEULANDLAB_07092026172307_SignedSEIntimation_Final.pdf

pdf

Download →
View document text
September 7, 2026 BSE Limited The National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers, Exchange Plaza, 25th Floor, Dalal Street, Bandra Kurla Complex Mumbai – 400 001 Bandra (E), Mumbai – 400 001 Scrip Code: 524558 Scrip Code: NEULANDLAB; Series: EQ Dear Sir/Madam, Sub: Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") Pursuant to Regulation 30 of the SEBI Listing Regulations, we wish to inform you that the Board of Directors of the Company, at its meeting held today, i.e., September 7, 2026, approved capital expenditure of ₹126 crores towards the purchase of approximately 134 acres of land situated at Auro Industrial City, Kakinada, Andhra Pradesh, including other related expenditure. The Company also has a right of first refusal to purchase an additional contiguous land parcel of approximately 66 acres at a later date, taking the potential aggregate land parcel at the said location to approximately 200 acres. The land is proposed to be used for the Company’s future expansion. The requisite details are as under: a) Existing Capacity N/A b) Existing Capacity Utilization N/A c) Proposed Capacity Addition N/A d) Period within which the proposed capacity is to be added e) Investment required ₹ 126 crores f) Mode of financing Through internal accruals g) Rationale For future expansion This is for your information and records. Yours sincerely, For Neuland Laboratories Limited Sarada Bhamidipati Company Secretary